YOKOYAMA Youhei | Department of Neurosurgery, Kyoto University Graduate School of Medicine
スポンサーリンク
概要
- YOKOYAMA Youheiの詳細を見る
- 同名の論文著者
- Department of Neurosurgery, Kyoto University Graduate School of Medicineの論文著者
関連著者
-
MIKUNI Nobuhiro
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
YOKOYAMA Youhei
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
MATSUMOTO Atsuhito
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
KIKUCHI Takayuki
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
YAMADA Shigeki
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
HASHIMOTO Nobuo
National Cerebral and Cardiovascular Center
-
MIYAMOTO Susumu
Department of Neurosurgery, Kyoto University Graduate School of Medicine
-
野中 聡
旭川医科大学耳鼻咽喉科・頭頸部外科学講座
-
Miyamoto Susumu
Department Of Neurosurgery Kyoto University Graduate School Of Medicine
-
Miyamoto Susumu
Department Of Internal Medicine Hokuriku Central Hospital
-
Yamada Shigeki
Department Of Medicine Jichi Medical University Omiya Medical Center
-
Hashimoto Nobuo
National Cardiovascular Center
-
Mikuni Nobuhiro
Department Of Neurosurgery Kyoto University Graduate School Of Medicine
-
Matsumoto Atsuhito
Department Of Neurosurgery Kyoto University Graduate School Of Medicine
-
Yokoyama Youhei
Department Of Neurosurgery Kyoto University Graduate School Of Medicine
-
Kikuchi Takayuki
Department Of Neurosurgery Kyoto University Graduate School Of Medicine
-
Kikuchi Takayuki
Department Of Chemistry Graduate School Of Science Osaka University
-
Miyamoto Susumu
Department Of Internal Medicine Himi City Hospital
-
Yamada Shigeki
Department Of Biochemistry Research Laboratory Of Applied Biochemistry Tanabe Seiyaku Co. Ltd.
-
MIYAMOTO Susumu
Kyoto University Graduate School of Medicine
-
Mikuni Nobuhiro
Department of Neurological Surgery, Sapporo Medical University, Japan
著作論文
- Intravenous Methylprednisolone Reduces the Risk of Propofol-Induced Adverse Effects During Wada Testing
- Intravenous Methylprednisolone Reduces the Risk of Propofol-Induced Adverse Effects During Wada Testing